Please login (Members) to view content or
(Nonmembers) this article.
0
No votes yet
Quality & Safety

Drug Diversion: Best Practices and Support for a Staff Assessment Process

Simran Kaur Ghuman
Katie Colleen A. Maletich
CJON 2020, 24(2), 195-198 DOI: 10.1188/20.CJON.195-198

The characteristics of opioid prescribing and administration in cancer centers include large quantities and less restrictive regulatory mandates governing cancer-related pain, which may increase the risk of drug diversion by staff members. The purpose of this article is to provide a framework for creating respectful investigative processes for staff suspected of drug diversion. Organizations, including cancer centers, need to engage in careful oversight of potential drug diversions while simultaneously promoting a psychologically safe work environment for individuals to successfully seek help.

AT A GLANCE

  • Building an open, nonpunitive culture in cancer centers to address diversion investigation processes can assist staff to feel comfortable raising concerns about colleagues.
  • Fostering supportive processes and a culture of safety around drug diversion investigations can convey empathy from the organization related to an employee’s livelihood and well-being. 
  • Drug diversion prevention programs need to ensure patient safety within an authentic and supportive work environment for staff with alleged or established substance use disorders.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or